APLN and neoplasm: Conversely, biased apelin ligands have also been shown to be effective in blocking detrimental actions of apelin, for example, in a mouse ectopic xenograft tumour model (glioblastoma) showed a reduction in tumour growth compared to control and improved survival of tumour-bearing mice [44].